Medicamen Biotech Limited
Medicamen Biotech Limited is an Indian listed company in the Pharmaceuticals & Biotechnology industry (Healthcare sector), traded under NSE: MEDICAMEQ and BSE: 531146 (ISIN INE646B01010).
It has a market capitalisation of ₹369 crore, a last close of ₹272.00 on 2026-10-19, a one-year return of -14.3%.
Valuation: a price-to-earnings ratio of 34.07x, a price-to-book ratio of 1.34x, a dividend yield of 0.4%.
Profitability: return on equity of 3.9%, return on capital employed of 6.2%, an operating margin of 9.5%.
Growth: sales growth of 12.0% a year over three years, net profit growth of -13.4% a year over three years.
Balance sheet and ownership: debt-to-equity of 0.17x, promoter holding of 40.5%.
| Metric | Value |
|---|---|
| Market capitalisation | 369 |
| Last close | ₹272.00 |
| P/E (TTM) | 34.07x |
| P/B | 1.34x |
| Dividend yield | 0.4% |
| ROE (FY) | 3.9% |
| ROCE (FY) | 6.2% |
| Operating margin (TTM) | 9.5% |
| Sales growth, 3-year CAGR | 12.0% |
| Profit growth, 3-year CAGR | -13.4% |
| Debt / equity | 0.17x |
| Promoter holding | 40.5% |
| 1-year return | -14.3% |
Loading the live page with the price chart, financial history, shareholding and recent filings. Data is end-of-day and rebuilt nightly; nothing here is investment advice. Financial statements · What each metric means